Defective Drugs and Medical Devices
Can Sleep Aid Drugs Contribute to Higher Car Crash Risk?
A new study finds a markedly increased risk of car crashes for new users of sleeping pills. The data shows there was an increased risk of car crashes for people who began taking Restoril (temazepam), Desyrel (trazodone) or Ambien (zolpidem), and this increased risk continued for about a year, according to University of Washington researchers.…
Read MoreHow to Get Compensation for Vaccine Injuries and Adverse Immunization Reactions
Between the day children are born and the age of six, the U.S. government mandates that children receive 49 doses of 14 vaccines. Vaccines can be beneficial and they are responsible for almost completely wiping out diseases such as measles and saving the lives of millions of children every year. The World Health Organization (WHO)…
Read MoreAnemia Drug Feraheme Assigned Boxed Warning by FDA
The Food and Drug Administration has assigned a boxed warning – the highest level there is – for Feraheme (ferumoxytol), an anti-anemia drug. Feraheme has been found to increase the risk of “serious, potentially fatal allergic reactions” specifically for “patients who have had an allergic reaction to any intravenous (IV) iron replacement product” according to…
Read MoreWhat is in Your Weight Loss Supplements?
As of 2013, the U.S. segment of the global market for weight loss products is more than $60 billion, with $2.69 billion for meal replacements and weight loss supplements. About half of American adults were trying to lose weight, according to a Marketdata Enterprises Inc. report. Millions of Americans take weight loss supplements in an…
Read MoreZofran Birth Defects Lawsuits
Zofran (Ondansetron) is a drug manufactured by GlaxoSmithKline, which was approved by the FDA in 1991 to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy and surgery. Ondansetron is a 5-HT3 receptor antagonist, which blocks the action of serotonin in the brain which is thought to cause vomiting and nausea. After Zofran was…
Read More